NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 84 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,149 | -10.0% | 1,339,331 | +12.2% | 0.00% | -20.0% |
Q3 2023 | $1,276 | -56.7% | 1,193,971 | +4.8% | 0.01% | -58.3% |
Q2 2023 | $2,948 | -22.9% | 1,138,843 | +21.4% | 0.01% | -29.4% |
Q1 2023 | $3,824 | +31.2% | 938,434 | +61.5% | 0.02% | +21.4% |
Q4 2022 | $2,914 | -98.6% | 581,223 | +3377.0% | 0.01% | +1300.0% |
Q2 2022 | $214,000 | -7.0% | 16,716 | +10.3% | 0.00% | 0.0% |
Q1 2022 | $230,000 | +666.7% | 15,153 | +770.9% | 0.00% | – |
Q4 2021 | $30,000 | -64.7% | 1,740 | -59.6% | 0.00% | – |
Q2 2021 | $85,000 | -54.3% | 4,305 | -54.5% | 0.00% | -100.0% |
Q2 2020 | $186,000 | +181.8% | 9,452 | +76.9% | 0.00% | – |
Q1 2020 | $66,000 | – | 5,343 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |